Phase II Copanlisib in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

NCT02391116 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Diffuse, Large B-Cell, Lymphoma

Interventions

DRUG: Copanlisib (Aliqopa, BAY80-6946)

Sponsor

Bayer